Purchases and Sales Made in Q2 2023 in Belite Bio, Inc (BLTE)
This table provides information about the institutional ownership of Belite Bio, Inc (BLTE) during Q2 2023. The information is specifically focused on institutions that hold shares of BELITE BIO, INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
211KNew |
$2.36M - $6.37M
|
211K
$12.4M
|
|
|
Aug 03, 2023
Q2 2023
|
Atria Wealth Solutions, Inc.
New York, NY |
BUY
|
- |
2.73K+ 0.34% |
$30.6K - $82.5K
|
814K
$47.9M
|
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
BUY
|
- |
921+ 7.39% |
$10.3K - $27.8K
|
13.4K
$787K
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
BUY
|
- |
180+ 150.0% |
$2.01K - $5.44K
|
300
$17.6K
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-91- 8.61% |
$1.02K - $2.75K
|
966
$56.8K
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-600- 57.8% |
$6.71K - $18.1K
|
438
$25.7K
|